The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

Justin Luermans

Showing 1-3 of 3 articles
Comparison of outcome after patent foramen ovale closure in older versus younger patients
Luermans J, Budts W, ten Berg J, Plokker H, Suttorp MJ, Post M
June 30, 2011 | 10.4244/EIJV7I2A35
Long-term outcome of percutaneous closure of secundum-type atrial septal defects in adults
Luermans J, Post M, ten Berg J, Plokker H, Suttorp MJ
November 15, 2010
The BioSTAR® device versus the CardioSEAL® device in patent foramen ovale closure: comparison of mid-term efficacy and safety
Van den Branden B, Luermans J, Post M, Plokker H, ten Berg J, Suttorp MJ
September 30, 2010

Latest news

NEW ISSUE
State of the Art on ViV-TAVI; Transseptal Punctures; Endovascular Closure and TF-TAVI; Percutaneous PVL Closure: Long-Term Outcomes; and more
October 20, 2021
STATE OF THE ART
Valve-in-valve TAVI: a practical overview
Giuseppe Tarantini et al.
October 20, 2021
AHEAD OF PRINT
TAVI in younger (<70 years old) patients: the AMTRAC registry
Guy Witberg et al.
October 22, 2021
AHEAD OF PRINT
Impact of LVOT calcification in transfemoral TAVI patients
L. Waldschmidt et al.
October 19, 2021
VIEWPOINT
My Stroke Story
Marco Noc
October 20, 2021
AHEAD OF PRINT
Impact of preprocedural biological markers on 10-year mortality in the SYNTAXES trial
Hironori Hara et al.
October 22, 2021
AHEAD OF PRINT
Serum caffeine causes adenosine-induced FFR overestimation
Hideaki Tanaka et al.
October 15, 2021
Coronary
Valvular disease
Heart failure
Peripheral
Hypertension
Stroke